Cardiac Blood Flow Patterns Associated With Left Ventricular Myocardial Damage
Launched by MEDICAL UNIVERSITY OF GRAZ · Aug 17, 2017
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • patients age 20-80 years,
- • patients with and without ischemic or non-ischemic myocardial injuries scheduled for routine cardiac magnetic resonance imaging,
- • ability to hold the breath,
- • ability to give informed consent
- Exclusion Criteria:
- • patients with metal devices or other magnetic material in or on the subjects body which will be hazardous for magnetic resonance investigation (e.g. heart pace-maker, brain aneurysm clip, nerve stimulators, electrodes, penile implants, colored contact lenses, patch to deliver medications through the skin, any metal implants as rods, joints, plates, pins, screws, nails or clips, embolization coil, or any metal fragments or shrapnel in the body),
- • patients with tendency toward claustrophobia,
- • hemodynamically unstable patients,
- • patients with (major) arrhythmia
- • pregnancy,
- • impaired kidney function indicated by creatin clearance lower than 60 ml/min (creatin clearance will be calculated according to Cockroft-Gault formula)
About Medical University Of Graz
The Medical University of Graz, a leading institution in Austria, is dedicated to advancing medical knowledge and improving patient care through innovative research and clinical trials. Renowned for its interdisciplinary approach, the university collaborates with various healthcare professionals and researchers to explore cutting-edge therapies and treatments. With a commitment to ethical standards and patient safety, the Medical University of Graz actively contributes to the global medical community by facilitating rigorous clinical trials that aim to translate scientific discoveries into practical applications for improved health outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Graz, Styria, Austria
Patients applied
Trial Officials
Michael Fuchsjäger, Univ.-Prof.
Study Chair
Medical Universtiy of Graz
Ursula Reiter, PD DI Dr.
Principal Investigator
Medical Universtiy of Graz
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials